Oxford Clinical Laboratory INC.

Oxford Clinical Laboratory INC. was paid $13.95M by Medicaid between Oct 2018 and Dec 2024, across 87 billing codes. Its largest line is U0003, Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r — 74% of everything it billed.

Compared with peers

Next to other Clinical Medical Laboratory providers in New Jersey

Rank by total paid#23 of 122

Median peer was paid$1.29M

This provider vs. median11×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	71	$446.88
2019	3,151	$6K
2020	18,337	$16K
2021	60,996	$810K
2022	353,572	$7.45M
2023	313,736	$5.62M
2024incomplete	55,616	$48K

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
U0003	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r	74%	225,085	86,599	$10.27M
U0005	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2	20%	184,840	73,601	$2.83M
G2023	Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source	4.8%	117,408	51,064	$665K
P9604	Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated trip charge	<1%	74,407	38,282	$23K
82306	Vitamin D; 25 hydroxy, includes fraction(s), if performed	<1%	10,592	9,272	$22K
80061	Lipid panel	<1%	14,846	13,087	$16K
86328		<1%	594	562	$12K
82607		<1%	4,227	3,665	$10K
87635	Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe	<1%	1,194	611	$9K
80050	General health panel	<1%	298	259	$8K
80053	Comprehensive metabolic panel	<1%	16,730	14,523	$8K
84443	Thyroid stimulating hormone (TSH)	<1%	11,173	9,786	$8K

75 more codes

84480		<1%	3,363	$7K
84439		<1%	6,703	$6K
86481		<1%	645	$6K
83970		<1%	2,148	$5K
83036	Hemoglobin; glycosylated (A1C)	<1%	13,517	$5K
82746		<1%	2,395	$4K
86769		<1%	741	$4K
84153		<1%	1,991	$3K
85025	Blood count; complete (CBC), automated, and automated differential WBC count	<1%	16,184	$2K
84154		<1%	786	$2K
P9603	Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated miles actually travelled	<1%	3,440	$2K
36415	Collection of venous blood by venipuncture	<1%	21,289	$2K
82248		<1%	2,836	$2K
83540		<1%	4,797	$2K
82728		<1%	2,470	$2K
82977		<1%	2,441	$1K
86141		<1%	652	$1K
84550		<1%	5,692	$1K
84100		<1%	4,128	$1K
83550		<1%	2,423	$1K
82550		<1%	1,183	$968.39
82150		<1%	871	$913.22
83690		<1%	865	$901.26
86762		<1%	322	$758.86
84436		<1%	1,651	$755.24
86765		<1%	322	$679.14
82043		<1%	5,473	$658.46
G0483	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed	<1%	65	$609.30
86735		<1%	320	$465.36
86803		<1%	356	$445.90
81001		<1%	8,221	$437.70
80048	Basic metabolic panel (calcium, ionized)	<1%	1,156	$375.97
81003		<1%	6,105	$361.64
87086	Culture, bacterial; quantitative colony count, urine	<1%	1,843	$339.53
82570		<1%	3,887	$292.55
83735		<1%	2,669	$269.14
83721		<1%	1,060	$266.80
86038		<1%	591	$233.68
83880		<1%	131	$224.30
86800		<1%	213	$159.21
84681		<1%	96	$150.41
86225		<1%	176	$137.46
85610		<1%	1,729	$133.06
80076		<1%	433	$111.09
84481		<1%	32	$106.45
85651		<1%	1,567	$99.26
84403		<1%	54	$88.78
87340		<1%	96	$82.32
83090		<1%	32	$81.69
82274		<1%	400	$78.92
86376		<1%	180	$60.75
86430		<1%	596	$58.44
85730		<1%	294	$58.24
88305	Level IV - Surgical pathology, gross and microscopic examination	<1%	17	$57.97
85652		<1%	474	$50.94
86706		<1%	99	$43.91
84466		<1%	14	$38.74
86704		<1%	41	$37.13
86677		<1%	30	$36.00
86780		<1%	12	$31.77
86140		<1%	271	$30.00
86703		<1%	30	$26.22
84156		<1%	1,061	$21.62
86060		<1%	17	$14.40
86592		<1%	31	$9.00
83615		<1%	28	$8.40
82565		<1%	81	$7.10
82985		<1%	52	$6.60
82270		<1%	14	$3.63
85007		<1%	56	$2.40
83516		0%	12	$0.00
82652		0%	14	$0.00
82610		0%	15	$0.00
86063		0%	12	$0.00
G2024	Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]) from an individual in a snf or by a laboratory on behalf of a hha, any specimen source	0%	74	$0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialHOROWITZ, SHULEM (OPERATIONS MANAGER)